Exhibits – EPI|Lifestyle 2022
Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease
This timely symposium highlights Cardiovascular Outcomes Trials of Omega-3 Fatty Acids in ASCVD. The focus is on the hottest topics on practical considerations to manage patients post-MI and post-stroke and at high risk of further cardiovascular disease.
Become an Exhibitor
Get your content and products in front of thousands of heart healthcare professionals. AHA has exhibiting opportunities for all of our medical conferences.